These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Principle and practice of clinical phase III studies]. Morant R. Onkologie; 2008; 31 Suppl 2():53-7. PubMed ID: 18487870 [Abstract] [Full Text] [Related]
4. [Pharmacy standards for clinical trials]. Terkola R. Onkologie; 2008; 31 Suppl 2():25-8. PubMed ID: 18487865 [Abstract] [Full Text] [Related]
5. [Principles and practice of clinical phase II studies]. Dittrich C. Onkologie; 2008; 31 Suppl 2():46-52. PubMed ID: 18487869 [Abstract] [Full Text] [Related]
8. [Pharmaceutical aspects of clinical trials: concepts of pharmacokinetic investigations]. Czejka M. Onkologie; 2008; 31 Suppl 2():29-33. PubMed ID: 18487866 [Abstract] [Full Text] [Related]
9. Improving the evaluation of new cancer treatments: challenges and opportunities. Rothenberg ML, Carbone DP, Johnson DH. Nat Rev Cancer; 2003 Apr; 3(4):303-9. PubMed ID: 12671669 [Abstract] [Full Text] [Related]
10. [Responsibilities of clinical pharmacology in the early phase of drug development]. Kuhlmann J. Med Klin (Munich); 2000 May; 95(1 Spec No):31-40. PubMed ID: 10851846 [Abstract] [Full Text] [Related]
12. Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan. Forster MD, Saijo N, Seymour L, Calvert H. Clin Cancer Res; 2010 Mar 15; 16(6):1737-44. PubMed ID: 20215555 [Abstract] [Full Text] [Related]
18. Microdialysis: an in vivo approach for measuring drug delivery in oncology. Brunner M, Müller M. Eur J Clin Pharmacol; 2002 Jul 15; 58(4):227-34. PubMed ID: 12136367 [Abstract] [Full Text] [Related]
20. New approaches in preclinical and clinical pharmacokinetics. Graham MA, Kaye SB. Cancer Surv; 1993 Jul 15; 17():27-49. PubMed ID: 8137345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]